Keer Biotechnology
Changshahsien
About Keer Biotechnology
Kerr Bio currently has a complete production line and powerful hardware facilities. In 2006, Kerr Biotech obtained the Chinese invention patent of "Probiotics Double-layer Encapsulation Process"; in 2008, it built a professional probiotic manufacturing factory; in 2017, it obtained the ISO22000 food safety quality management system certification and started the second generation of 16S rRNA microorganisms Microbial gene sequencing system; in 2018, established a research section on probiotic precision nutrition products. In 2019, the company created the first "Yiduan Health Experience Center".
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $439.1K
- Funding stage: Seed
- Last round: Angel (Nov 2008)
- Website: krydy.com
- Phone: +86 0731 88573790
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/keer-biotechnology-3597801 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.